| Janna Michelle Mortensen, MS CCC-SLP | |
|
13010 Ne 20th St Ste 300, Bellevue, WA 98005-2054 | |
| (425) 644-6328 | |
| Not Available |
| Full Name | Janna Michelle Mortensen |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 13010 Ne 20th St Ste 300, Bellevue, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073857926 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | LL60391663 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Janna Michelle Mortensen, MS CCC-SLP 14321 Se 6th St Apt M207, Bellevue, WA 98007-7057 Ph: (949) 735-4275 | Janna Michelle Mortensen, MS CCC-SLP 13010 Ne 20th St Ste 300, Bellevue, WA 98005-2054 Ph: (425) 644-6328 |
News Archive
The number of underrepresented minorities among U.S. medical school faculty remains low, even as the U.S. population becomes increasingly diverse.
The current health care reform bills approved by the House and the Senate seek to expand health insurance coverage while containing costs; however, the proposed policy changes are not guaranteed to improve health for individuals or society, according to a "Perspective" article by faculty of Weill Cornell Medical College in the Jan. 6 New England Journal of Medicine.
When Kerstin Stenson, MD, describes the innovative technique she is helping develop to fight cancer, it seems like she's describing a Tom Clancy military espionage novel.
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, today announced updated results from its ongoing multicenter, randomized, open-label global Phase 2b clinical trial investigating the efficacy and safety of aldoxorubicin compared with doxorubicin as first-line therapy in subjects with metastatic, locally advanced or unresectable soft tissue sarcomas.
Cellectis stem cells, a Business Unit of Cellectis Group, a premier provider of stem cell derived products and technologies, today announces the launch of a human iPS derived hepatocyte product, hiPS-HEP.
› Verified 4 days ago
Alexandra Marie Gomez, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1417 116th Ave Ne, Suite 110, Bellevue, WA 98004 Phone: 425-688-5900 Fax: 425-688-5912 | |
Elise Morrison, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 Fax: 425-502-8425 | |
Andrea Nicole Jamieson, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 16120 Ne 8th St, Bellevue, WA 98008 Phone: 425-747-4004 Fax: 425-747-1069 | |
Mrs. Katherine Jeanne Oberhofer, MS CCC-SLP Speech-Language Pathologist Medicare: Accepting Medicare Assignments Practice Location: 1417 116th Ave Ne Ste 110, Bellevue, WA 98004 Phone: 425-688-5911 Fax: 425-688-5912 | |
Mrs. Lori Anne Price, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 12 Lummi Key, Bellevue, WA 98006 Phone: 425-643-2919 Fax: 425-657-0691 | |
Mackenzie Bush, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 13333 Ne Bel Red Rd Ste 100, Bellevue, WA 98005 Phone: 501-352-0101 | |
Genenvieve Decantis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5150 Village Park Dr Se, Bellevue, WA 98006 Phone: 425-657-0620 |